Brain natriuretic peptide and cancer
Bando, Sachiko Tokushima University
添木, 武 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
松浦, 朋美 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
飛梅, 威 Tokushima University KAKEN研究者をさがす
伊勢, 孝之 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
楠瀬, 賢也 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
山口, 浩司 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
八木, 秀介 Tokushima University KAKEN研究者をさがす
福田, 大受 Tokushima University KAKEN研究者をさがす
岩瀬, 俊 Tokushima University KAKEN研究者をさがす
山田, 博胤 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
若槻, 哲三 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
島袋, 充生 Tokushima University KAKEN研究者をさがす
六車, 直樹 Tokushima University KAKEN研究者をさがす
高山, 哲治 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
Kishimoto, Ichiro National Cerebral and Cardiovascular Center Research Institute
寒川, 賢治 National Cerebral and Cardiovascular Center Research Institute
佐田, 政隆 Tokushima University 徳島大学 教育研究者総覧 KAKEN研究者をさがす
Natriuretic peptides have been proposed as biomarkers of cardiovascular disease, especially heart failure. Brain natriuretic peptide (BNP) has also been shown to be upregulated at the transcriptional and translational levels by pro-inflammatory cytokines in cardiac myocytes. Although we often measure plasma BNP levels in cancer patients, it remains unknown whether cancer-related inflammation affects the plasma BNP levels. We investigated the relationship between the BNP and human cancers.
We retrospectively studied 2,923 patients in whom the plasma BNP levels and serum C-reactive protein (CRP) were measured and echocardiography was performed. Patients with clinically evident heart failure (NYHA II or higher), heart disease requiring medical treatment or surgery, renal dysfunction, and inflammatory disease were excluded. There were 234 patients in the final analysis. Blood sampling was performed before surgery and chemotherapy. In addition, we evaluated the relationship between the inflammation and plasma BNP levels in mouse models of colon cancer.
Of the 234 patients, 80 were diagnosed with cancer. Both the plasma BNP and serum CRP levels were significantly higher in cancer patients than those without. There were no significant differences in the echocardiographic parameters. There was a significant positive correlation between the plasma BNP and serum CRP levels in cancer patients (r = 0.360, P<0.01) but not in those without. In cancer patients, only the CRP correlated with the BNP independent of the age, creatinine level, hypertension, and body mass index. In addition, in nude mice with subcutaneous colon cancer, the plasma BNP level was elevated compared with that in non-cancer mice, and there was a significant relationship between the plasma BNP and serum levels of the inflammatory markers.
In cancer patients, as well as colon cancer model mice, the plasma BNP levels were elevated, possibly due to cancer-related inflammation. The effect of cancer on the BNP levels should be considered when using BNP as an indicator of heart failure in cancer patients.
Copyright: © 2017 Bando et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
pone_12_6_e0178607.pdf 2.06 MB